PEER REVIEWED, EVIDENCE-BASED INFORMATION FOR CLINICIANS AND RESEARCHERS IN NEUROSCIENCE

Tag: ziprasidone

Letters to the Editor

Letter to the Editor: A case of Paranoid Schizophrenia and severe antipsychotic-induced Parkinson’s Disorder treated with a combination of olanzapine and lurasidone

Oleg V. Tcheremissine, MD, and Danielle Englert, MD Dr. Tcheremissine

October 21, 2013 No Comments

Letters to the Editor

Letter to the Editor Regarding “A Risperidone-Induced Prolactinoma Resolved when a Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report” with Author Response

Innov Clin Neurosci. 2013;10(2):10–16

February 6, 2013 No Comments

A Risperidone-Induced Prolactinoma Resolved when a Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report

by Gail T. Arcari, MEd; Asante K. Mendes, MD; and

September 1, 2012 No Comments

Real-world Data on Atypical Antipsychotic Medication Side Effects

by Elisa Cascade; Amir H. Kalali, MD; Sagar Mehra; and

July 27, 2010 No Comments

Recommendations for Pharmacological Management of Inpatient Aggression in Children and Adolescents

Parikshit Deshmukh, MD; Guarav Kulkarni, MD; and Drew Barzman, MD

February 15, 2010 No Comments

Use of Intramuscular Ziprasidone for the Control of Acute Psychosis or Agitation in an Inpatient Geriatric Population: An Open-Label Study

by Alina R. Rais, MD; Kristi Williams, MD; Theodor Rais,

January 15, 2010 No Comments

LATEST DIGITAL EDITION

ARCHIVES

Innovations in Clinical Neuroscience is a subsidiary of Matrix Medical Communications

contact

Links

About

Topics

©2024 Matrix Medical Communications copyright all right reserved.